These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 17400912
1. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, Hwang IG, Park YH, Ahn JS, Jung CW, Kim K, Ahn YC, Kang WK, Park K, Kim WS. Blood; 2007 Aug 01; 110(3):972-8. PubMed ID: 17400912 [Abstract] [Full Text] [Related]
2. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Hong JY, Ryu KJ, Park C, Hong M, Ko YH, Kim WS, Kim SJ. Oncotarget; 2017 Feb 21; 8(8):13782-13791. PubMed ID: 28099151 [Abstract] [Full Text] [Related]
3. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland. Ziarkiewicz M, Wołosz D, Dzieciątkowski T, Wilczek E, Dwilewicz-Trojaczek J, Jędrzejczak WW, Gierej B, Ziarkiewicz-Wróblewska B. Arch Immunol Ther Exp (Warsz); 2016 Apr 21; 64(2):159-69. PubMed ID: 26084760 [Abstract] [Full Text] [Related]
7. Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma. Miller IJ. Appl Immunohistochem Mol Morphol; 2019 Mar 21; 27(3):165-173. PubMed ID: 28800008 [Abstract] [Full Text] [Related]
8. CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma. Chuang WY, Chang H, Shih LY, Wang PN, Chang YS, Lin TL, Hung YS, Yeh CJ, Ueng SH, Tang TC, Kuo MC, Dunn P, Wu JH, Kao HW, Ou CW, Wan YL, Hsueh C. Virchows Arch; 2015 Nov 21; 467(5):571-82. PubMed ID: 26369546 [Abstract] [Full Text] [Related]
9. Utility of Epstein-Barr Viral Load in Blood for Diagnosing and Predicting Prognosis of Lymphoma: A Comparison with Epstein-Barr Virus-Encoded RNA in Situ Hybridization. Song J, Kim JY, Kim S, Park Y. J Mol Diagn; 2022 Sep 21; 24(9):977-991. PubMed ID: 35718093 [Abstract] [Full Text] [Related]
10. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma. Okamoto A, Yanada M, Miura H, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Mizuta S, Akatsuka Y, Yoshikawa T, Mizoguchi Y, Nakamura S, Okamoto M, Emi N. Cancer Sci; 2015 Nov 21; 106(11):1576-81. PubMed ID: 26353084 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma. Liang JH, Lu TX, Tian T, Wang L, Fan L, Xu J, Zhang R, Gong QX, Zhang ZH, Li JY, Xu W. Clin Microbiol Infect; 2015 Jun 21; 21(6):596-602. PubMed ID: 25743579 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time. Chang ST, Lu YH, Lu CL, Weng SF, Lin SH, Kuo SY, Chuang YT, Takeuchi K, Ohshima K, Chuang SS. J Clin Pathol; 2014 Apr 21; 67(4):326-32. PubMed ID: 24218026 [Abstract] [Full Text] [Related]
13. Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly. Lee J, Park M, Lee MH, Woo HJ, Kim HW, Yang JY, Eom YB, Kim SH, Yoo C, Kim JB. Int J Clin Exp Pathol; 2015 Apr 21; 8(7):7859-68. PubMed ID: 26339350 [Abstract] [Full Text] [Related]
14. Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma: A Reappraisal of 23 Japanese Patients Based on EBV Association and PD-L1 Expression in Tumor Cells. Kawano T, Tsuyuki Y, Suzuki Y, Shimada K, Kato S, Takahara T, Mori M, Nakaguro M, Sakakibara A, Nakamura S, Satou A. Am J Surg Pathol; 2021 Dec 01; 45(12):1606-1615. PubMed ID: 34534136 [Abstract] [Full Text] [Related]
15. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma. Kim JH, Cho H, Sung H, Jung AR, Lee YS, Lee SW, Ryu JS, Chae EJ, Kim KW, Huh J, Park CS, Yoon DH, Suh C. Sci Rep; 2021 Feb 03; 11(1):2880. PubMed ID: 33536508 [Abstract] [Full Text] [Related]
16. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis. Gao X, Li J, Wang Y, Liu S, Yue B. PLoS One; 2018 Feb 03; 13(6):e0199398. PubMed ID: 29920566 [Abstract] [Full Text] [Related]
17. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age? Monabati A, Vahedi A, Safaei A, Noori S, Mokhtari M, Vahedi L, Zamani M. Asian Pac J Cancer Prev; 2016 Feb 03; 17(4):2285-9. PubMed ID: 27221931 [Abstract] [Full Text] [Related]
18. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells. Ohashi A, Kato S, Okamoto A, Inaguma Y, Satou A, Tsuzuki T, Emi N, Okamoto M, Nakamura S. Histopathology; 2017 Jul 03; 71(1):89-97. PubMed ID: 28231401 [Abstract] [Full Text] [Related]
19. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly. Uccini S, Al-Jadiry MF, Scarpino S, Ferraro D, Alsaadawi AR, Al-Darraji AF, Moleti ML, Testi AM, Al-Hadad SA, Ruco L. Hum Pathol; 2015 May 03; 46(5):716-24. PubMed ID: 25704629 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus infection, drug resistance and prognosis in Korean T- and NK-cell lymphomas. Jung CK, Lee KY, Kim Y, Han K, Shim SI, Kim BK, Kang CS. Pathol Int; 2001 May 03; 51(5):355-63. PubMed ID: 11422793 [Abstract] [Full Text] [Related] Page: [Next] [New Search]